Market Place
Sourcing Support
All News #Library
Biotech
Remix Therapeutics Presents REM-422 Phase 1/2 ARIA Trial Results
21 Apr 2026 //
GLOBENEWSWIRE
Remix Therapeutics Granted FDA Fast Track Designation for REM-422
19 Mar 2026 //
GLOBENEWSWIRE
Remix Therapeutics To Present at Guggenheim Health Conference
03 Nov 2025 //
GLOBENEWSWIRE
Remix Therapeutics Reveals Encouraging Phase 1 Data For REM-422
24 Oct 2025 //
GLOBENEWSWIRE
Remix Therapeutics To Unveil REM-422 Ph 1 Data at AACR-NCI-EORTC
13 Oct 2025 //
GLOBENEWSWIRE
Remix Therapeutics Appoints Linda C. Bain to Board of Directors
15 Apr 2025 //
GLOBENEWSWIRE
Remix Therapeutics to Present at Stifel 2025 Oncology Forum
31 Mar 2025 //
GLOBENEWSWIRE
Remix Therapeutics to Attend Leerink Global Healthcare Conference
27 Feb 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.